Small Stocks, Big Money

RedChip Companies
  • 0.0 (0)
  • BUSINESS
  • UPDATED SEMIWEEKLY
Small Stocks, Big Money

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

  1. 48 MIN. AGO

    Inside OKYO Pharma’s (NASDAQ: OKYO) Phase 2 Trials with CEO Dr. Gary Jacob

    OKYO Pharma Limited (NASDAQ: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of DED and NCP, with ordinary shares listed for trading on the NASDAQ Capital Market. OKYO is focused on the discovery and development of novel molecules to treat inflammatory DED and ocular pain. In addition to the recently completed Phase 2 trial of OK-101 to treat DED patients, OKYO is also evaluating OK-101 to treat NCP patients with the just announced opening of a Phase 2 trial to treat the debilitating conditions of NCP. Visit www.redchip.com/stocks/okyo to learn more. OKYO Pharma (OKYO) is a client of RedChip Companies, Inc. OKYO agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in August 2024, and 50,000 stock options with a $1 strike price and five-year expiration, for six month of investor awareness services. RedChip intends to and will, if possible, exercise and sell all of its options immediately upon eligibility, and you may be buying as RedChip is selling. OKYO also agreed to pay RedChip a one-time forty-four thousand dollar fee for a 10-day national TV ad campaign aired June 11 through June 25, 2024, a one-time twenty-thousand dollar fee for a five-day national TV ad campaign aired August 5 through August 9, 2024, a one-time thirty-eight-thousand five-hundred dollar fee for a 10-day national TV ad campaign aired October 16 through October 29, 2024, and a one-time #33,000 cash fee for a 10-day national TV ad campaign aired November 7 through November 20, 2024. Read our full disclosures at: www.redchip.com/legal/disclosures

    8 min

  2. NOV 26

    Inside VSee Health’s Telehealth Revolution: Exclusive Interview with Co-CEO Dr. Imo Aisiku

    VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health's system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. With a focus on patient disease state telemedicine and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies and a team of neurointensivists, neurologists, and tele-radiologists that treat and coordinate care for acutely ill patients 24/7/365 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain trauma and a wide range of neurological conditions. Visit www.redchip.com/stocks/VSEE to learn more. VSee Health (VSEE) is a client of RedChip Companies. VSEE agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in October 2024, for six month of investor awareness services. VSEE also agreed to pay RedChip a $50,000 fee for a national TV ad campaign aired weekdays from November 11 to November 22, 2024. VSee is a client of RedChip Companies. Read our full disclosures at: www.redchip.com/legal/disclosures

    8 min

  3. NOV 19

    Inside Can-Fite BioPharma’s (NASDAQ: CANF) Clinical Pipeline with CEO Motti Farbstein

    Can-Fite BioPharma is an advanced clinical stage drug development company with a platform of oral drugs designed to address multi-billion-dollar markets in the treatment of oncology and inflammatory diseases. The Company’s lead drug candidate, Piclidenoson recently reported topline results in a Phase III trial for psoriasis. Can-Fite’s liver drug, Namodenoson, is being evaluated in a Phase IIb trial for the treatment of NASH a Phase III trial for hepatocellular carcinoma (HCC), and the Company is planning a Phase IIa study in pancreatic cancer. Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S. Food and Drug Administration. Namodenoson has also shown proof of concept to potentially treat other cancers including colon, prostate, and melanoma. CF602, the Company’s third drug candidate, has shown efficacy in the treatment of erectile dysfunction. These drugs have an excellent safety profile with experience in over 1,600 patients in clinical studies to date. Visit www.redchip.com/stocks/canf to learn more. Can-Fite Biopharma (CANF) is a client of RedChip Companies, Inc. CANF agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in April 2024, for four month of investor awareness services. CANF also agreed to pay RedChip one-time cash fees of fifty-thousand dollars, twenty-two thousand five hundred dollars, and forty-five thousand dollars, for two-week national TV ad campaigns aired weekdays from June 3 to June 14, 2024, June 19 to June 25, 2024, and October 2 to October 15, 2024, respectively. For full disclosure, visit RedChip.com/disclosures

    6 min

  4. NOV 12

    How MUSQ ETF is Reshaping Music Investments: CEO David Shulhof Explains

    The MUSQ Global Music Industry ETF (MUSQ) offers investors focused exposure to the growing global music industry. The fund aims to replicate the performance of the MUSQ Global Music Industry Index (MUSQIX), which rebalances quarterly and includes publicly traded companies and royalty funds with significant revenues tied to music. MUSQ provides access to key segments such as music streaming, live events and ticketing, content distribution, satellite and broadcast radio, and music equipment and technology. Launched in July 2023, the fund is positioned to benefit from the evolving digital landscape, including the rise of streaming and AI-driven content creation. With the global music industry projected to grow significantly in the coming years, MUSQ is an attractive vehicle for investors seeking to capture long-term growth trends in this dynamic sector. The ETF invests in companies that are integral to the modern music ecosystem, providing thematic and technology-driven exposure in a diversified, global format. Visit RedChip.com to learn more. MUSQ is a client of RedChip Companies, Inc. MUSQ agreed to pay RedChip Companies, Inc. a $5,000 monthly cash fee, beginning in August 2024, for three month of investor awareness services. MUSQ also agreed to pay RedChip a one-time $20,000 fee for a national TV ad campaign aired weekdays from October 4 to October 15, 2024, and a one-time $20,000 cash fee for a national TV ad campaign aired weekdays from November 1 to November 14, 2024. For full disclosure, visit RedChip.com/disclosures

    6 min

  5. OCT 22

    The Future of Oncology: Calidi’s Stem Cell-Based Platforms for Fighting Cancer

    Calidi Biotherapeutics (NYSE American:CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California. Visit RedChip.com to learn more. Calidi Biotherapeutics (CLDI) is a client of RedChip Companies, Inc. CLDI agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in March 2024, and 25,000 shares of Rule 144 stock for 6 months of investor awareness services. CLDI also agreed to pay RedChip a one-time $40,000 fee for a national TV ad campaign aired weekdays from April 3 to April 17, 2024, a one-time $40,000 fee for a national TV ad campaign aired weekdays from May 28 to June 11, 2024, a one-time $40,000 fee for a national TV ad campaign aired weekdays from July 7 to August 2, 2024, a one-time $20,000 fee for a national TV ad campaign aired weekdays from August 5 to August 9, 2024, and a one-time $20,000 fee for a national TV ad campaign aired weekdays from October 16 to October 24, 2024. For full disclosure, visit RedChip.com/disclosures

    8 min

  6. OCT 8

    How Alliance Entertainment (Nasdaq AENT) is Optimizing Operations for Continued Margin Improvement

    Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailers. The company partners with nearly every major film studio, music label, and video game maker, including Disney, Sony, Universal, Warner Bros., Universal Music, Sony Music, Warner Music, Microsoft, and Nintendo, to distribute their products to retailers worldwide. With over 325,000 in stock SKUs, Alliance supplies major retailers like Walmart, Amazon, and Best Buy, as well as thousands of independent stores. In fiscal 2024, Alliance generated over $1.1 billion in revenue, with more than $250 million from exclusive distribution deals. As the dominant force in the physical media market, Alliance's unmatched scale and reach secure its leadership position. Looking ahead, the company remains committed to fueling its growth through strategic acquisitions, leveraging its proven ability to expand and strengthen its portfolio in an evolving industry. Disclosure RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.   Alliance Entertainment (AENT) is a client of RedChip Companies, Inc. AENT agreed to pay RedChip Companies, Inc. a $7,500 monthly cash fee, beginning in September 2024, for six month of investor awareness services. AENT also agreed to pay RedChip a one-time forty-thousand dollar fee for a 10-day national TV ad campaign aired weekdays from June 3 through June 14, 2024.   For full disclosure, visit RedChip.com/disclosures.

    12 min

  7. OCT 1

    The Gold Rush of 2024: Christopher Gerteisen’s Vision for Nova Minerals and Beyond

    Nova Minerals Limited is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project, comprised of 514 km 2 of State of Alaska mining claims, which contains multiple mining complexes across a 35 km long mineralized corridor of over 20 advanced Gold and Antimony prospects, including two already defined multi-million ounce resources, and several drill ready Antimony prospects with massive outcropping stibnite vein systems observed at surface. The 85% owned project is located 150 km northwest of Anchorage, Alaska, USA, in the prolific Tintina Gold Belt, a province which hosts an over 220 million ounce (Moz) documented gold endowment and some of the world's largest gold mines and discoveries including, Barrick's Donlin Creek Gold Project and Kinross Gold Corporation's Fort Knox Gold Mine. The belt also hosts significant Antimony deposits and was a historical North American Antimony producer. Disclosure RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.   Nova Minerals (NVA) is a client of RedChip Companies, Inc. NVA agreed to pay RedChip Companies, Inc. a $5,000 monthly cash fee, beginning in August 2024, and 600,000 shares of NVA’s ASX-listed shares, for 12 months of investor awareness services. RedChip will receive an additional 600,000 shares of NVA’s ASX-listed shares when the average five-day trading volume reaches 100,000 ADS per day or NVA’s market cap reaches $75 million within 12 months of the agreement. NVA also agreed to pay RedChip a ten-thousand dollar digital ad budget, a fifty-thousand dollar fee for a national TV ad campaign aired weekdays in August 2024, and a one-time ninety-thousand dollar cash fee for a four-week national TV ad campaign aired in October and November 2024.   For full disclosure, visit RedChip.com/disclosures.

    10 min

  8. SEP 24

    Interview with Founder of MUSQ Global Music Industry ETF

    Tracking the MUSQ Global Music Industry Index (MUSQIX), the MUSQ Global Music Industry ETF (NYSE: MUSQ) includes publicly traded companies with core interests in music streaming, content and distribution, live events, satellite and broadcast radio, and music equipment and technology. RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.   MUSQ is a client of RedChip Companies, Inc. MUSQ agreed to pay RedChip Companies, Inc. a $5,000 monthly cash fee, beginning in August 2024, for three month of investor awareness services. MUSQ also agreed to pay RedChip a one-time twenty-thousand dollar cash fee for a two-week national TV ad campaign aired weekdays from June 3 to June 14, 2024 and a one-time twenty-two thousand five hundred dollar cash fee for a one week national TV ad campaign.   For full disclosure, visit RedChip.com/disclosures.

    7 min
See All (75)

About

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.

Information

  • Creator
    RedChip Companies
  • Years Active
    2023 - 2024
  • Episodes
    75
  • Rating
    Clean
  • Copyright
    © RedChip Companies
  • Show Website
    Small Stocks, Big Money

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada